Advertisement
AIMD vs MBOT
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AIMD is a StrongBuy and MBOT is a Hold.
AIMD's Stochastic Oscillator is remaining in oversold zone for 10 days
The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator shows that the ticker has stayed in the oversold zone for 7 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
Following a +6.30% 3-day Advance, the price is estimated to grow further. Considering data from situations where AIMD advanced for three days, in 147 of 186 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.
AIMD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Moving Average Convergence Divergence Histogram (MACD) for AIMD turned negative on September 25, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In 40 of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at 85%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AIMD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for AIMD entered a downward trend on October 13, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 10 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 90 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.979) is normal, around the industry mean (1.792). P/E Ratio (-0.353) is within average values for comparable stocks, (7.746). Projected Growth (PEG Ratio) (0.120) is also within normal values, averaging (5.470). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. AIMD's P/S Ratio (588.235) is very high in comparison to the industry average of (32.028).
The Tickeron Price Growth Rating for this company is 92 (best 1 - 100 worst), indicating slightly worse than average price growth. AIMD’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AIMD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock worse than average.
MBOT in -1.33% downward trend, declining for three consecutive days on October 21, 2026
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where MBOT declined for three days, in 284 of 328 cases, the price declined further within the following month. The odds of a continued downward trend are 87%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Moving Average Convergence Divergence Histogram (MACD) for MBOT turned negative on September 23, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In 38 of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at 81%.
The Aroon Indicator for MBOT entered a downward trend on October 21, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Indicator shows that the ticker has stayed in the oversold zone for 20 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
MBOT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 10 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 29 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.916) is normal, around the industry mean (2.923). P/E Ratio (-3.760) is within average values for comparable stocks, (2.388). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.052). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (263.158) is also within normal values, averaging (40.124).
The Tickeron Price Growth Rating for this company is 91 (best 1 - 100 worst), indicating slightly worse than average price growth. MBOT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MBOT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
AIMD | MBOT | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 92 | 67 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 90 Overvalued | 29 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 100 | 97 | |
PRICE GROWTH RATING 1..100 | 92 | 91 | |
P/E GROWTH RATING 1..100 | 10 | 10 | |
SEASONALITY SCORE 1..100 | 50 | 90 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
MBOT's Valuation (29) in the Biotechnology industry is somewhat better than the same rating for AIMD (90) in the null industry. This means that MBOT’s stock grew somewhat faster than AIMD’s over the last 12 months.
MBOT's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as AIMD (100) in the null industry. This means that MBOT’s stock grew similarly to AIMD’s over the last 12 months.
MBOT's SMR Rating (97) in the Biotechnology industry is in the same range as AIMD (100) in the null industry. This means that MBOT’s stock grew similarly to AIMD’s over the last 12 months.
MBOT's Price Growth Rating (91) in the Biotechnology industry is in the same range as AIMD (92) in the null industry. This means that MBOT’s stock grew similarly to AIMD’s over the last 12 months.
MBOT's P/E Growth Rating (10) in the Biotechnology industry is in the same range as AIMD (10) in the null industry. This means that MBOT’s stock grew similarly to AIMD’s over the last 12 months.
| AIMD | MBOT | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 85% | 2 days ago 84% |
| Stochastic ODDS (%) | 2 days ago 89% | N/A |
| Momentum ODDS (%) | N/A | N/A |
| MACD ODDS (%) | 2 days ago 85% | 2 days ago 81% |
| TrendWeek ODDS (%) | 2 days ago 88% | 2 days ago 84% |
| TrendMonth ODDS (%) | 2 days ago 88% | 2 days ago 84% |
| Advances ODDS (%) | 21 days ago 79% | N/A |
| Declines ODDS (%) | 2 days ago 90% | 2 days ago 87% |
| BollingerBands ODDS (%) | 2 days ago 89% | 2 days ago 72% |
| Aroon ODDS (%) | 2 days ago 90% | 2 days ago 86% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
AIMD’s FA Score shows that 1 FA rating(s) are green while MBOT’s FA Score has 2 green FA rating(s).
- AIMD’s FA Score: 1 green, 4 red.
- MBOT’s FA Score: 2 green, 3 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
AIMD’s TA Score shows that 4 TA indicator(s) are bullish while MBOT’s TA Score has 2 bullish TA indicator(s).
- AIMD’s TA Score: 4 bullish, 3 bearish.
- MBOT’s TA Score: 2 bullish, 3 bearish.
Price Growth
AIMD (@Electronic Equipment/Instruments) experienced а -8.32% price change this week, while MBOT (@Medical/Nursing Services) price change was -5.18% for the same time period.
The average weekly price growth across all stocks in the @Electronic Equipment/Instruments industry was -3.39%. For the same industry, the average monthly price growth was -13.90%, and the average quarterly price growth was -16.41%.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -1.62%. For the same industry, the average monthly price growth was -10.72%, and the average quarterly price growth was -10.29%.
Reported Earning Dates
AIMD is expected to report earnings on Nov 12, 2026.
MBOT is expected to report earnings on Nov 11, 2026.
Industries' Descriptions
@Electronic Equipment/Instruments (-3.39% weekly)This industry manufactures electronic products used in various critical and sophisticated technologies, including laser-based systems, circuit and continuity testers, electro-optical measuring instruments and high-speed precision weighing and inspection equipment. Some major companies operating in this business are Canon Inc., Keysight Technologies Inc., and Fortive Corp.
@Medical/Nursing Services (-1.62% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
Advertisement
AIMD and
Correlation & Price change
A.I.dvisor tells us that AIMD and AGPU have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AIMD and AGPU's prices will move in lockstep.
| Ticker / NAME | Correlation To AIMD | 1D Price Change % | ||
|---|---|---|---|---|
| AIMD | 100% | -2.24% | ||
| AGPU - AIMD | 30% Poorly correlated | +5.90% | ||
| KEYS - AIMD | 30% Poorly correlated | +2.15% | ||
| CODX - AIMD | 30% Poorly correlated | -0.82% | ||
| MBOT - AIMD | 29% Poorly correlated | -0.78% | ||
| CRMD - AIMD | 28% Poorly correlated | +2.91% | ||
More | ||||